With over 25 years of experience in the field of microbial systems, Wacker Biotech GmbH is a preferred partner for the contract manufacturing of therapeutic proteins (biologics). Our focus is on the development of stable, high-efficiency processes, and GMP-compliant production in our certified multifunctional facility. Our customers include both mid-sized and globally-active pharmaceutical and biotech companies.
Wacker Biotech’s experience with therapeutic proteins dates back to the 1980s. Wacker Biotech GmbH has been a wholly-owned WACKER Group subsidiary since January 2005. In 2014, acquisition of Scil Proteins Production GmbH in Halle expanded the production capacity by a 1,500-liter line and added refolding expertise to the portfolio. The GMP plant in Halle started operating in 2007. EMA approval has already been obtained for one of the products manufactured there and commercial production has begun.
The highly competent CMO team of some 160 experienced employees in Jena and Halle offers its customers excellent and extensive services in the field of microbiology.